Robbins, Michael Darron,Graziano, Robert F.,Bezman, Natalie
申请号：
AU2015358462
公开号：
AU2015358462A1
申请日:
2015.12.03
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The invention described herein relates to therapeutic dosing regimens and combinations thereof for use in enhancing the therapeutic efficacy of anti-CS1 antibodies in combination with an anti-Programmed Death-1 (PD-1) antibody.
